Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which of these drugs can be given safely to a patient with renal disease?

Morphine. ***Morphine*** - Morphine is primarily metabolized in the **liver** and excreted as glucuronide conjugates, making it generally safer in patients with **renal impairment**. - While careful dosing and monitoring are still needed, its elimination is less dependent on **kidney function** compared to other drugs listed. *Phenacetin* - Phenacetin is an **NSAID** that is known to cause **analgesic nephropathy**, leading to chronic interstitial nephritis and papillary necrosis. - Its use is contraindicated in patients with existing **renal disease** due to the high risk of further kidney damage. *Tetracycline* - Tetracyclines can accumulate in patients with **renal impairment**, leading to increased side effects such as **nephrotoxicity** and increased **blood urea nitrogen (BUN)**. - Specifically, some tetracyclines (e.g., outdated tetracycline) can cause a **Fanconi-like syndrome** in susceptible individuals. *Aminoglycoside* - Aminoglycosides are extensively excreted by the kidneys and are highly **nephrotoxic**, causing acute tubular necrosis. - Their use in **renal disease** requires significant dose adjustments and careful monitoring of plasma levels to prevent further kidney damage and ototoxicity.

Q: Which of the following drugs is least likely to cause pancreatitis as a side effect?

Captopril. ***Captopril*** - **Captopril**, an ACE inhibitor, is among the drugs **least commonly associated** with drug-induced pancreatitis [1]. - While ACE inhibitors can have various side effects, **pancreatitis is exceedingly rare** and not a primary concern compared to other agents [3]. *Furosemide* - **Furosemide**, a loop diuretic, has been linked to cases of **drug-induced pancreatitis**, although the mechanism is not fully understood. - The risk is generally low but documented, making it a more likely cause than captopril. *Valproic acid* - **Valproic acid** is well-known for its association with **pancreatitis**, with a significantly higher risk compared to many other medications. - Pancreatitis can be a serious and dose-dependent side effect of valproic acid therapy. *Didanosine* - **Didanosine**, an antiretroviral nucleoside reverse transcriptase inhibitor, is particularly notable for causing **pancreatitis** as a common and severe adverse effect [2]. - Patients on didanosine require close monitoring for signs of pancreatitis due to its elevated risk [2].

Q: All of the following cause hypothyroidism except which of the following?

Captopril. ***Captopril*** - **Captopril** is an **ACE inhibitor** primarily used to treat hypertension and heart failure; it is not known to cause hypothyroidism. - Its mechanism of action involves inhibiting the conversion of angiotensin I to angiotensin II, which does not directly affect thyroid hormone synthesis or release. *PAS (Para-aminosalicylic acid)* - **PAS** can interfere with **iodine uptake** by the thyroid gland, leading to reduced thyroid hormone synthesis. - While historically used for tuberculosis, its thyroid-suppressing effect is a recognized side effect that can induce **hypothyroidism**. *Lithium* - **Lithium** can inhibit the **release of thyroid hormones** from the thyroid gland and can also interfere with iodine metabolism. - It is frequently associated with the development of **hypothyroidism** in patients treated for bipolar disorder. *Amiodarone* - **Amiodarone** contains a large amount of **iodine**, which can induce both hyperthyroidism and hypothyroidism. - Its complex effects on thyroid function include inhibition of **T4 to T3 conversion** and direct cytotoxicity to thyroid follicular cells.

Q: What is the antidote of choice for Belladonna poisoning?

Physostigmine. ***Correct: Physostigmine*** - **Physostigmine** is an **acetylcholinesterase inhibitor** that increases acetylcholine levels in the synaptic cleft, effectively reversing the anticholinergic effects of Belladonna poisoning. - It is particularly useful for central nervous system manifestations such as **delirium**, **hallucinations**, and **seizures** associated with Belladonna toxicity. - Physostigmine is preferred because it **crosses the blood-brain barrier**, making it effective for both peripheral and central anticholinergic symptoms. *Incorrect: Flumazenil* - **Flumazenil** is a **benzodiazepine receptor antagonist** used to reverse the sedative effects of benzodiazepine overdose. - It is inappropriate for Belladonna poisoning, which involves **antimuscarinic** effects, not GABAergic effects. *Incorrect: Disulfiram* - **Disulfiram** is used in the treatment of **chronic alcoholism** to produce an unpleasant reaction when alcohol is consumed by inhibiting aldehyde dehydrogenase. - It has no role or antidote activity in cases of **Belladonna poisoning**. *Incorrect: Atropine* - **Atropine** itself is an **anticholinergic agent** that is chemically similar to Belladonna alkaloids (atropine and scopolamine are the main toxic components). - Administering atropine in Belladonna poisoning would **exacerbate the anticholinergic toxidrome** rather than act as an antidote.

Q: What is considered a toxic serum level of lithium?

2.6. **2.6 mEq/L** - **Lithium toxicity** is generally considered to occur when serum lithium levels are above **1.5 mEq/L** with severe toxicity typically seen at levels above **2.5 mEq/L**. - At a level of **2.6 mEq/L**, patients are at high risk for significant neurological symptoms such as seizures, coma, and even death. *0.6 mEq/L* - A serum lithium level of **0.6 mEq/L** is within the normal therapeutic range, which is typically between **0.6 and 1.2 mEq/L**. - At this concentration, lithium is generally effective for bipolar disorder and other conditions with minimal risk of toxicity. *12 mEq/L* - A serum lithium level of **12 mEq/L** would represent an **extremely severe and likely fatal level of toxicity**, far beyond typical therapeutic or even severely toxic ranges. - Survival at such a high concentration would be highly improbable, as it would cause irreversible organ damage and profound central nervous system depression. *<0.6 mEq/L* - A serum lithium level of **less than 0.6 mEq/L** is considered subtherapeutic, meaning it is unlikely to be effective in treating bipolar disorder or other conditions. - While not toxic, such a low level would indicate a lack of therapeutic benefit and potential for symptom recurrence.

Q: Pralidoxime acts in organophosphorus poisoning by:

Regenerating Cholinesterase. ***Regenerating Cholinesterase*** - Pralidoxime (2-PAM) is an **oxime** that works by **reactivating acetylcholinesterase** inhibited by organophosphates [1], [2], [3]. - It does this by binding to the phosphorous atom of the organophosphate, thereby cleaving the bond between the organophosphate and the enzyme [2], [3]. - Most effective when given **early**, before "aging" of the enzyme-inhibitor complex occurs [1], [3]. *Inhibiting cholinesterase* - This is the mechanism of action of **organophosphates** themselves, not pralidoxime [3]. - Pralidoxime's role is to **reverse this inhibition**. *Cholinergic action* - Pralidoxime itself does not have a direct cholinergic action; its effect is indirect by **restoring functioning cholinesterase** [2]. - Medications like **atropine** are used in organophosphate poisoning to block the effects of excessive acetylcholine, which is a cholinergic action [1]. *Blocking muscarinic receptors* - This is the mechanism of **atropine**, which is co-administered with pralidoxime in organophosphate poisoning [1]. - Atropine blocks the muscarinic effects of acetylcholine accumulation, while pralidoxime reactivates the enzyme [3]. - Pralidoxime works by **enzyme reactivation**, not receptor blockade [2].

Q: Administration of which of the following will reverse respiratory depression caused by opioids?

Naloxone. ***Naloxone*** - **Naloxone** is a pure **opioid receptor antagonist** that rapidly reverses all effects of opioid overdose, including respiratory depression - It has high affinity for **mu-opioid receptors**, which mediate both respiratory depression and analgesia - Naloxone is the **gold standard antidote** for opioid overdose and life-threatening respiratory depression - It reverses opioid effects within 1-2 minutes when given intravenously *Kappa receptor blocker* - **Kappa receptors** primarily mediate dysphoria, sedation, and some analgesia - The life-threatening **respiratory depression** from opioid overdose is primarily mediated by **mu receptors**, not kappa receptors - Selective kappa blockade would not effectively reverse mu-opioid induced respiratory depression *Delta receptor blocker* - **Delta opioid receptors** are primarily involved in modulating pain perception and emotional responses - They have minimal direct involvement in **respiratory depression** compared to mu receptors - Blocking delta receptors would not effectively counteract respiratory depression induced by **mu-opioid agonists** like morphine, fentanyl, or heroin *Adrenergic receptor stimulator* - **Adrenergic stimulators** (e.g., epinephrine) act on the sympathetic nervous system and may cause bronchodilation - They do not reverse the **central mechanism** of opioid-induced respiratory depression, which occurs at the brainstem respiratory centers via opioid receptors - While they might provide some cardiovascular support, they do not address the underlying **CNS depression** and are not appropriate antidotes for opioid toxicity

Q: Sirolimus is more likely than cyclosporine to cause which of the following?

Thrombocytopenia. ***Thrombocytopenia*** - **Sirolimus** frequently causes **myelosuppression**, leading to **thrombocytopenia** and leukopenia. - While both sirolimus and cyclosporine can have side effects, **thrombocytopenia** is a more prominent and distinguishing adverse effect of sirolimus. *Hypertension* - **Cyclosporine** is well-known for causing **hypertension** due to its effect on the renin-angiotensin-aldosterone system and endothelial dysfunction. - While sirolimus can cause hypertension, it is generally less pronounced compared to cyclosporine. *Osteoporosis* - **Corticosteroids** are the primary immunosuppressants associated with **osteoporosis** due to their effects on bone metabolism. - Neither sirolimus nor cyclosporine is a major direct cause of osteoporosis. *Renal insufficiency* - **Cyclosporine** is distinctively associated with **nephrotoxicity**, leading to acute and chronic **renal insufficiency** through vasoconstriction and tubular damage. - While sirolimus can impact renal function indirectly or in combination with calcineurin inhibitors, cyclosporine's direct nephrotoxic effect is more significant.

Q: Which of the following is the most appropriate treatment for severe nicotine poisoning?

Atropine. ***Atropine*** - **Atropine** is the most appropriate pharmacological treatment among the options for managing the **muscarinic symptoms** of severe nicotine poisoning, as it acts as a **competitive antagonist** at muscarinic acetylcholine receptors [1]. - Nicotine initially stimulates and then paralyzes nicotinic acetylcholine receptors at autonomic ganglia and neuromuscular junctions, leading to a biphasic toxidrome with both muscarinic and nicotinic effects [1]. - Severe cases often present with prominent **cholinergic overdrive** (bradycardia, excessive salivation, bronchorrhea, bronchospasm) that responds to atropine. - **Note:** Overall management of severe nicotine poisoning primarily involves **supportive care** (airway management, mechanical ventilation), with atropine used for symptomatic relief of muscarinic effects. *Neostigmine* - **Neostigmine** is an **acetylcholinesterase inhibitor** that increases acetylcholine levels at the synapse. - This would exacerbate the cholinergic effects of nicotine poisoning and is therefore contraindicated. *Phentolamine* - **Phentolamine** is an **alpha-adrenergic blocker** used to treat hypertensive crises, particularly those caused by catecholamine release. - While nicotine can cause initial sympathetic stimulation and catecholamine release, phentolamine does not address the primary cholinergic toxicity of severe nicotine poisoning. *Trimethaphan* - **Trimethaphan** is a **ganglionic blocker** that can block both sympathetic and parasympathetic ganglia at nicotinic receptors [2]. - While theoretically it might prevent some nicotinic effects, it is obsolete and rarely used due to its non-selective nature and potential for severe hypotension and other side effects, making it unsuitable compared to supportive care and targeted atropine therapy [2].

Q: Which of the following is NOT a known cause of gynecomastia?

Pyrazinamide. ***Pyrazinamide*** - **Pyrazinamide** is an **antituberculosis drug** known for causing **hyperuricemia** and **hepatotoxicity**, but it is **not commonly associated with gynecomastia**. - Its mechanism of action does not directly interfere with **hormone balance** in a way that typically leads to breast tissue enlargement. *Isoniazid (INH)* - **Isoniazid** can cause **gynecomastia** in some patients, possibly due to its effects on **liver metabolism** and subsequent alterations in **estrogen-androgen balance**. - It interferes with **vitamin B6 metabolism**, which can indirectly affect **steroid hormone synthesis** and breakdown. *Cimetidine* - **Cimetidine** is a **histamine H2-receptor antagonist** that can cause gynecomastia by acting as an **antiandrogen**. - It directly binds to **androgen receptors**, blocking the action of androgens and leading to an imbalance in the **estrogen-androgen ratio**. *Digitalis* - **Digitalis** (digoxin) is a **cardiac glycoside** that has a **steroid-like structure** and can exhibit **estrogenic effects**. - These estrogenic properties can lead to increased breast tissue growth and **gynecomastia** in male patients, especially with long-term use.

Question 1

Which of these drugs can be given safely to a patient with renal disease?

Accepted Answer

Morphine

Answer

Aminoglycoside

Answer

Phenacetin

Answer

Tetracycline

Question 2

Which of the following drugs is least likely to cause pancreatitis as a side effect?

Accepted Answer

Captopril

Answer

Furosemide

Answer

Valproic acid

Answer

Didanosine

Question 3

All of the following cause hypothyroidism except which of the following?

Accepted Answer

Captopril

Answer

Lithium

Answer

PAS

Answer

Amiodarone

Question 4

What is the antidote of choice for Belladonna poisoning?

Accepted Answer

Physostigmine

Answer

Flumazenil

Answer

Disulfiram

Answer

Atropine

Question 5

What is considered a toxic serum level of lithium?

Accepted Answer

2.6

Answer

0.6

Answer

12

Answer

<0.6

Question 6

Pralidoxime acts in organophosphorus poisoning by:

Accepted Answer

Regenerating Cholinesterase

Answer

Inhibiting cholinesterase

Answer

Cholinergic action

Answer

Blocking muscarinic receptors

Question 7

Administration of which of the following will reverse respiratory depression caused by opioids?

Accepted Answer

Naloxone

Answer

Kappa receptor blocker

Answer

Delta receptor blocker

Answer

Adrenergic receptor stimulator

Question 8

Sirolimus is more likely than cyclosporine to cause which of the following?

Accepted Answer

Thrombocytopenia

Answer

Osteoporosis

Answer

Renal insufficiency

Answer

Hypertension

Question 9

Which of the following is the most appropriate treatment for severe nicotine poisoning?

Accepted Answer

Atropine

Answer

Neostigmine

Answer

Phentolamine

Answer

Trimethaphan

Question 10

Which of the following is NOT a known cause of gynecomastia?

Accepted Answer

Pyrazinamide

Answer

Isoniazid (INH)

Answer

Cimetidine

Answer

Digitalis

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?